TERT and hepatocellular carcinoma: Decreased OS in patients with TERT mutations (p = 0.006), but not significant association (p = 0.19) after adjustment for tumor stage.In patients with HCC on LC, trend toward significance after adjustment for tumor stage (p = 0.051)